News
If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...
HealthDay News — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes, and other metabolic diseases.
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, i ...
Explore more
16h
Us Weekly on MSNQueen Latifah Reveals If 'Equalizer' Could Return After Surprise CancelationFor many CBS viewers, The Equalizer came to an end too soon — but is there a chance Queen Latifah‘s show could return? “It is ...
The success of Eli Lilly & Co. 's weight-loss and diabetes drugs has pushed the company's stock to new heights, helping the ...
The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan, it’s $44,000. The U.S. pays three times more for branded prescription drugs, on average, than other rich countries. It ...
The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U ...
The $78 bln oil major urgently needs a hands-on chair who its new activist can work with. Former BHP Chair Ken MacKenzie, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results